Clinical Trials Logo

Dermatomycoses clinical trials

View clinical trials related to Dermatomycoses.

Filter by:
  • None
  • Page 1

NCT ID: NCT05901961 Completed - Clinical trials for Fungal Foot Infection

Effectiveness and Safety of Whitfield's Solution, Zinc Oxide Nanoparticles Solution or Combination for the Treatment of Fungal Feet Infection

WhitfieldZinc
Start date: June 2, 2023
Phase: Phase 4
Study type: Interventional

This study aimed to study the efficacy of Whitfield's solution, zinc oxide nanoparticles solution, and the combination of Whitfield's and zinc oxide nanoparticles solution in treating fungal feet infection.

NCT ID: NCT05777525 Completed - Skin Lesion Clinical Trials

Use of Essential Oils as Natural Therapies

Start date: February 11, 2023
Phase: Phase 3
Study type: Interventional

Mycosis is defined as a fungal infection caused by the implantation of etiological agents that compromises the dermis and subcutaneous tissue. Dermatophytosis is a fungal infection caused by dermatophytes, being the main cause of superficial mycoses and constituting an important public health problem. The production or development of infections is due in any case to the loss of ability to protect the exterior of the skin epidermis and, in the case of nails, to the fact that the nail apparatus does not have cell-mediated immunity effective, thus being more susceptible to infection than other parts of the skin. Although these infections can be bacterial, fungal, or viral, the investigators will focus on fungal infections. There are numerous studies that suggest the suitability of EOs as an alternative treatment for fungal infections. Due to this, in this project the investigators will analyze one of the most important infections within the podiatric health of the population, in terms of its incidence, pathogenesis, diagnostic methods, etc., and for this our research will be focused on examining whether there is improvements in the skin of patients with dermatophytosis treated with cream enriched with natural oils, in our case tea tree oil, verified by ultrasound.

NCT ID: NCT05770245 Completed - Dermatophytoses Clinical Trials

Novel Electrolyzed Water Spray Treatment Mild Dermatophytosis

Start date: January 29, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to test whether spraying the skin of patients of patients by use of the novel electrolyzed water spray will produce improvement in the condition of mild dermatophytosis.

NCT ID: NCT04880980 Completed - Clinical trials for Terbinafine Adverse Reaction

Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.

Start date: March 15, 2021
Phase: Phase 3
Study type: Interventional

Study would be conducted to compare the efficacy and safety of double than usual dose oral terbinafine versus itraconazole in treatment of dermatophyte infections of skin in patient presenting at dermatology department of Pak Emirates Military Hospital, Rawalpindi, Pakistan.

NCT ID: NCT02493738 Completed - Candidiasis Clinical Trials

A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers

Start date: July 2015
Phase: Phase 1
Study type: Interventional

Study Objectives: - To evaluate the pharmacokinetics (PK) of orally administered Lozanoc under fasted and fed condition in healthy male subjects - To compare the pharmacokinetics (PK) of orally administered Lozanoc and Sporanox under fed condition in healthy male subjects - To evaluate the safety and tolerability of single oral dose of Lozanoc and Sporanox in Korean healthy male subjects

NCT ID: NCT01646580 Terminated - Dermatomycoses Clinical Trials

Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children

Start date: October 2008
Phase: Phase 4
Study type: Interventional

Ciclopirox olamine (Ciclochem®) is a pyridone broad spectrum antifungal drug which has shown activity on dermatophytes, yeasts, moulds, actinomycetes and some bacteria. Its mechanism of action is based on a fungicidal activity by inhibiting the cellular captation of essential substances needed for the metabolism and growth of the fungi. On the other hand, this drug binds irreversibly with cell structures as mitochondria, ribosomes, microsomes and cell wall. After dermal application, Ciclopirox olamine undergoes skin penetration, being only absorbed a 1,5% of the applied dose. Clinical efficacy has been studied in patients above 10 years with superficial dermatomycoses (dermatophytoses, candidiasis and pityriasis versicolor) and the percentage of clinical healing ranged from 77% to 91% after 2-4 weeks of twice a day topical application. In all the studies, the safety profile has been very good, showing only a very low rate of adverse events of mild to moderate intensity. There are very few previous available data on the application of this compound in children under 10 years of age. A single study had been performed with a solution formulation in patients from 6 to 29 months with diaper candidiasis, showing good efficacy and tolerability in these patients. The present study aims to show the safety and tolerability of ciclopirox olamine in a cream formulation in patients from 3 months to 10 years with dermatomycoses.

NCT ID: NCT00722189 Completed - Skin Mycoses Clinical Trials

Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

Start date: July 2008
Phase:
Study type: Observational

An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses

NCT ID: NCT00351897 Completed - Pulsed Dye Laser Clinical Trials

The Efficacy of Pulsed Dye Laser in Dermatophytosis

Start date: April 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether Pulsed Dye Laser therapy are effective in the treatment of Cutaneous Dermatophytosis.